← Open Payments lookup

KATE CHARRON: Open Payments

NPI 1801047337 · HAMDEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$930 in 49 payments from 9 companies in 2025. Trend: 2023 $1,040 · 2024 $797 · 2025 $930

Food & beverage: $930
CompanyPaymentsAmount
ABBVIE INC.23$377
Madrigal Pharmaceuticals8$221
Takeda Pharmaceuticals U.S.A., Inc.9$150
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$49
Ardelyx, Inc.2$46
Janssen Biotech, Inc.2$32
Digestive Care, Inc.1$22
Ipsen Biopharmaceuticals, Inc1$21
Gilead Sciences, Inc.1$14

Products named: REZDIFFRA, LINZESS, CREON, ENTYVIO, RINVOQ, XIFAXAN, IBSRELA, VIBERZI.

Industry payments across CT — which companies pay providers there.